ストックスクリーナーアプリを入手
0.4539
2.37%
0.0105
アフターアワーズ：
.45
-0.0039
-0.86%
前日終値:
$0.4434
開ける：
$0.4433
24時間の取引高:
302.38K
Relative Volume:
0.06
時価総額：
$2.97M
収益：
$79,300
当期純損益:
$-6.92M
株価収益率:
-0.0239
EPS:
-18.9818
ネットキャッシュフロー:
$-5.34M
1週間 パフォーマンス:
-27.91%
1か月 パフォーマンス:
-1.58%
6か月 パフォーマンス:
-52.72%
1年 パフォーマンス:
-71.81%
1日の値動き範囲:
$0.4402
$0.47
1週間の範囲:
$0.4325
$0.6234
52週間の値動き範囲:
$0.35
$3.20
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
VRAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.4539 | 2.90M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-31 | 開始されました | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd (VRAX) 最新ニュース
Virax Biolabs secures $5 million in private placement to advance immunology research - MSN
Virax Biolabs Group (NASDAQ:VRAX) Shares Down 11.3% – Here’s Why - Defense World
A new trading data show Virax Biolabs Group Ltd (VRAX) is showing positive returns. - Setenews
Penny Stocks To Keep An Eye OnDecember 3rd - MarketBeat
Why Virax Biolabs Group Limited stock is seen as undervalued2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Virax Biolabs Secures $5 Million in Private Placement to Advance Immunology Research - TipRanks
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Virax Biolabs (Nasdaq: VRAX) closes $5 million raise, cash runway into 2028 - Stock Titan
US Market Preview | VRAX Surges 108.0%; ADP Jobs Data Misses Expectations, Futures Rise; NVDA's OpenAI Investment Pending - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Healthy Upside Potential: Transocean Ltd (RIG) - Setenews
Ready to Jump After Recent Trade: Virax Biolabs Group Ltd (VRAX) - setenews.com
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally - Benzinga
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.86% - Investing.com UK
United States shares higher at close of trade; Dow Jones Industrial Average up 0.86% By Investing.com - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.86% - Investing.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Scienjoy (NASDAQ: SJ): Deep-Value, Cash-Rich Tech with Mixed-Reality Upside More Inside - openPR.com
Virax Biolabs Group Limited (VRAX) Stock: Surges as 2026 Strategy and Clinical Milestones Ignite Investor Interest - parameter.io
Virax Biolabs : Announces $5 Million Private Placement - marketscreener.com
Virax Biolabs (Nasdaq: VRAX) announces $5 million private placement for working capital - Stock Titan
Crude Oil Gains 1%; Macy's Reports Strong Q3 Results - Benzinga
BC-Most Active Stocks - Yahoo Finance
Ming Shing Group (NASDAQ: MSW) adds Tianhang Zhao to Board, audit chair named - Stock Titan
US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Benzinga
Virax Biolabs stock rockets after clinical progress in post-infection diagnostics By Investing.com - Investing.com South Africa
Virax Biolabs stock rockets after clinical progress in post-infection diagnostics - Investing.com India
Credo Technology Group (NASDAQ: CRDO) to present at Barclays 23rd Global Technology Conference on Dec. 10 - Stock Titan
The LGL Group (NYSE American: LGL) moves warrant deadline from Dec. 9 to Dec. 16, 2025 - Stock Titan
Nu Holdings (NYSE: NU) to add Brazil banking license without changing Nubank brand - Stock Titan
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders - PR Newswire
Virax Biolabs Releases Interim Financial Results for September 2025 - TipRanks
Virax Biolabs Group (VRAX) Stock Analysis Report | Financials & Insights - Benzinga
Will Virax Biolabs Group Limited stock maintain dividend yield - Newser
Mitsubishi UFJ (NYSE: MUFG) details ¥250B share buyback and 200M-share cancellation - Stock Titan
Is Virax Biolabs Group Limited stock a defensive play in 2025Global Markets & Daily Profit Focused Stock Screening - moha.gov.vn
A new trading data show Foremost Clean Energy Ltd (FMST) is showing positive returns. - Setenews
Get in on Titan Mining Corp’s (TII) buy-in window today! - Setenews
A Look at Virax Biolabs Group Ltd (VRAX) Shares in the Recent Past Indicates Growth - setenews.com
Republic Power (NASDAQ: RPGL) Notified of Noncompliance for 2025 Form 20-F Filing - Stock Titan
MUFG (NYSE: MUFG) rings NYSE Closing Bell to honor 20th merger anniversary - Stock Titan
EPWK Holdings (Nasdaq: EPWK) receives Nasdaq delisting notice under Rule 5250(c)(1) - Stock Titan
How Virax Biolabs Group Limited stock reacts to bond yieldsVolume Spike & Daily Growth Stock Tips - newser.com
Why Virax Biolabs Group Limited stock is favored by pension fundsMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
Virax Biolabs Group (NASDAQ:VRAX) Trading Down 0% – Time to Sell? - Defense World
Will Virax Biolabs Group Limited stock gain from lower inflationTrade Ideas & Daily Stock Trend Reports - newser.com
Ranking Virax Biolabs Group Limited among high performing stocks via toolsJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Identifying reversal signals in Virax Biolabs Group LimitedJuly 2025 Intraday Action & Low Drawdown Investment Strategies - newser.com
Will earnings trigger a reversal in Virax Biolabs Group LimitedGap Down & Free Real-Time Volume Trigger Notifications - newser.com
Using Python tools to backtest Virax Biolabs Group Limited strategies - newser.com
Virax Biolabs Group Ltd (VRAX) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):